Ischemic Stroke Surgery Market is predicted to reach USD 7.26 billion at a CAGR of 8.70% during the forecast period

Market Research Future (MRFR) has published a cooked research report on the “Global Ischemic Stroke Surgery Market” that contains the information from 2018 to 2035. 

The ischemic stroke surgery market is expected to register a CAGR of 8.70% to reach USD 7.26 billion by 2035 during the forecast period of 2022 to 2035.

Global Ischemic Stroke Surgery Market Highlights

Ischemic stroke is a potentially fatal and disabling condition. It is the second leading cause of death in the world and a major cause of adult disability. Hypertension, type 2 diabetes, high blood cholesterol, cardiovascular disease, sedentary lifestyle, atrial fibrillation, smoking, and alcohol consumption are all modifiable risk factors. Nonmodifiable risk factors, such as age and gender, are also relatively few. The rising prevalence of acute ischemic stroke cases, as well as technological advancements in surgical procedures, are driving the global ischemic stroke surgery market.

Increasing physical inactivity, adoption & launch of technologically advanced products, and rising demand for minimally invasive procedures are the key factors fueling the growth of the global ischemic stroke surgery market. Additionally, with R&D activities and investments, the market is expected to grow further in the coming years. However, a lack of medical facilities and a shortage of skilled professionals is expected to hamper the market growth during the forecast period.

Segment Analysis

The global ischemic stroke surgery market has been divided based on type of surgery, product type and end user.

Based on the type of surgery, the global market has been divided into thrombectomy, revascularization surgery, carotid endarterectomy, angioplasty, and others. The thrombectomy segment accounted for the largest market share in 2021 and the revascularization surgery segment is projected to register the highest CAGR during the forecast period

The global market has been segmented based on product type into catheters, aspiration system, guidewire, microcatheter, and others. The catheters segment accounted for the largest market share in 2021 and the microcatheter segment is projected to register the highest CAGR during the forecast period.

The global ischemic stroke surgery market, on the basis of end user, has been categorized into hospitals & clinics, ambulatory surgical centers, and others. The hospitals & clinics segment accounted for the largest market share in 2021 and the ambulatory surgical centers segment is projected to register the highest CAGR during the forecast period.

Explore In-depth Details: Ischemic Stroke Surgery Market Research Report

Regional Analysis

Based on region, the global ischemic stroke surgery market has been segmented into North America, Europe, Asia-Pacific, and the Rest of the World. The North America market is further divided into the US and Canada. The Europe market has been segmented into Germany, France, the UK, Italy, Spain, and the rest of Europe. The market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The rest of the world is further segmented into the Middle East, Africa, and Latin America.

North America is dominating the market due to an increase in the number of acute ischemic stroke patients and advanced and innovative technological diagnostics. Additionally, the high demand for endovascular thrombectomy is expected to further enhance the market's growth.

Europe held a significant share in the global ischemic stroke surgery market. The rising number of people with sedentary lifestyles, physical inactivity, poor diet, smoking, and obesity; the elderly population; the improved survival rate; and increased research projects for the use of innovative technology in the treatment of ischemic stroke are fuelling the market growth in the region.

Asia-Pacific is expected to be the fastest-growing ischemic stroke and surgery market, mainly due to the high incidence of chronic diseases such as diabetes and hypertension that lead to ischemic strokes, an increase in the elderly population, and government initiatives. In addition, factors such as rising R&D activities further boost the market in the Asia-Pacific region.

The ischemic stroke surgery market in the rest of the world is growing dramatically due to the high prevalence of hypertension and CVDs and increasing government support to establish infrastructure for healthcare.

Key Findings of the Study

• The global ischemic stroke surgery market is expected to reach USD 7.26 billion by 2035 at a CAGR of 8.70% during the forecast period.


• The North America region accounted for the largest share of the global market, owing to the increase in the number of acute ischemic stroke patients and advanced & innovative technological diagnostics in the region.


• Based on type of surgery, the revascularization surgery segment is expected to register the fastest growth at a CAGR of 10.67% during the forecast period.


• Based on product type, the catheters segment accounted for the largest market share in 2021 and is anticipated to reach USD 2,095.14 million by 2035.


• Based on end user, the hospitals & clinics segment accounted for the largest market share in 2021 and is anticipated to reach USD 4,403.75 million by 2035 at a CAGR of 8.51% during the forecast period.


• Some of the key players operating in the Ischemic stroke surgery market are Stryker (US), Medtronic PLC (Ireland), Johnson & Johnson Services Inc. (US), Boston Scientific Corporation (US) and Penumbra, Inc. (US).